Overview
Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure
Description
The patient diagnosed with heart failure is randomized to either the experimental or control arm. The patient in the experimental arm downloads a telemonitoring application where they enter their pressure and body weight data, which is revised by the hospital team via a platform. Patients from both arms complete a questionnaire during enrollment and during two follow-ups (3 months and 6 months) to examine various dimensions.
Eligibility
Inclusion Criteria:
- Have been diagnosed with chronic CS according to the ESC guidelines;
- Over 18 years of age;
- Patients admitted to hospital or with access to first aid within the last year;
- Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application);
- Wi-Fi or 3G coverage at home;
- Ability to give written informed consent.
Exclusion Criteria:
- Severe psychiatric disorder
- Inability to use portable technologies
- Patients unable to use the equipment provided
- Patients who deny consent to study participation